Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in Veracyte, Inc. (NASDAQ:VCYT) by **12.5%**, acquiring an additional **22,074 shares**, bringing its total ownership to **198,592 shares** valued at approximately **$5.89 million**.
• Several hedge funds, including **Vanguard Group** and **ArrowMark Colorado Holdings**, also raised their stakes in Veracyte, indicating growing institutional interest in the company.
• Analysts have mixed opinions on Veracyte's stock, with **nine "buy" ratings**, but recent price targets suggest a decline, reflecting a **moderate buy** rating as the average target price stands at **$40.90**.

Universal Beteiligungs und Servicegesellschaft mbH boosted its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 12.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 198,592 shares of the biotechnology company's stock after buying an additional 22,074 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.25% of Veracyte worth $5,888,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its stake in Veracyte by 1,267.6% during the 1st quarter. Versant Capital Management Inc now owns 930 shares of the biotechnology company's stock valued at $28,000 after purchasing an additional 862 shares during the last quarter. GF Fund Management CO. LTD. purchased a new stake in shares of Veracyte in the fourth quarter worth about $64,000. Sterling Capital Management LLC boosted its stake in shares of Veracyte by 810.2% in the fourth quarter. Sterling Capital Management LLC now owns 2,421 shares of the biotechnology company's stock worth $96,000 after buying an additional 2,155 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Veracyte in the fourth quarter worth about $152,000. Finally, Neuberger Berman Group LLC acquired a new position in Veracyte in the 4th quarter worth about $201,000.

Analysts Set New Price Targets

VCYT has been the subject of a number of analyst reports. UBS Group reduced their price target on Veracyte from $49.00 to $42.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Guggenheim reduced their price target on Veracyte from $45.00 to $37.00 and set a "buy" rating for the company in a report on Wednesday, April 9th. Wall Street Zen raised Veracyte from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Finally, Needham & Company LLC reduced their target price on Veracyte from $51.00 to $41.00 and set a "buy" rating for the company in a report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Veracyte currently has an average rating of "Moderate Buy" and a consensus price target of $40.90.

Veracyte Price Performance

Shares of VCYT traded up $0.24 during midday trading on Thursday, reaching $24.21. 272,927 shares of the stock were exchanged, compared to its average volume of 1,120,426. Veracyte, Inc. has a twelve month low of $19.73 and a twelve month high of $47.32. The business's 50-day moving average price is $26.38 and its 200 day moving average price is $31.86. The company has a market capitalization of $1.90 billion, a price-to-earnings ratio of 58.86 and a beta of 2.07.

Veracyte Profile

Veracyte, Inc engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H.